Total elbow arthroplasty for primary and metastatic tumor

Orthop Traumatol Surg Res. 2016 Jun;102(4):459-65. doi: 10.1016/j.otsr.2015.12.026. Epub 2016 Apr 12.

Abstract

Background: Prostheses can be used in elbow reconstruction in both primary and metastatic lesions. Several authors have reported their experience with different types of implant, but not with modular prostheses.

Hypothesis: Limb salvage using an elbow prosthesis is effective in obtaining good functional results and reliable local tumor control.

Material and methods: Forty-seven patients treated at the Rizzoli Institute for elbow neoplasm from 1990 to 2012 were evaluated. There were 30 primary tumors (64%), 24 bone tumors and 6 soft tissue sarcomas, and 17 bone metastases. Elbow reconstruction used a modular prosthesis in 25 patients and a standard prosthesis in 22. Reconstruction was primary in 30 patients and secondary in 17.

Results: At last control, 15 (32%) were dead of disease (DOD) at a mean follow-up of 35 months, 12 (25%) were alive with disease (AWD) at a mean follow-up of 29 months, 19 (40%) showed no evidence of disease (NED) at a mean follow-up of 80 months. Early complications were related to unexpected neurological damage, observed in 12 patients (25%): in 5 cases the deficit resolved in a mean 6 months; in the others, no or only partial recovery was observed. Two implants (4%) developed infection: 1 was treated with antibiotic therapy, and the other required implant revision. One implant showing cement extrusion was revised. In 3 patients (6%) radiography showed a radiolucent halo around the stem (2 humeral, 1 ulnar); no measures were taken, as the patients were completely asymptomatic at every follow-up. In 3 patients (6%) partial resorption of the allograft was observed on X-ray, but remained unchanged at last follow-up, without pain or functional impairment. Seven local recurrences (15%) were observed, at a mean of 16 months after surgery; 5 were treated by resection and/or radiotherapy, and 2 by amputation. Mean functional scores on MEPS and MSTS were respectively 84% and 22/30 (73%).

Conclusions: Elbow prostheses provided better function in primary than in metastatic tumor. Elbow prosthesis reconstruction after tumor resection is a viable option both for primary and secondary bone neoplasms.

Type of study: Therapeutic.

Level of evidence: IV, retrospective study.

Keywords: Elbow; Limb-salvage; Metastases; Modular prosthesis; Prosthesis; Tumors.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Arthroplasty, Replacement, Elbow / instrumentation*
  • Arthroplasty, Replacement, Elbow / methods
  • Bone Neoplasms / secondary
  • Bone Neoplasms / surgery*
  • Child
  • Elbow Joint / surgery*
  • Elbow Prosthesis*
  • Female
  • Follow-Up Studies
  • Humans
  • Limb Salvage / instrumentation*
  • Limb Salvage / methods
  • Male
  • Middle Aged
  • Retrospective Studies
  • Sarcoma / secondary
  • Sarcoma / surgery*
  • Soft Tissue Neoplasms / secondary
  • Soft Tissue Neoplasms / surgery*
  • Treatment Outcome
  • Young Adult